Join the Conversation

See what doctors are saying about the new AcrySof^® IQ Toric IOL

The AcrySof^® IQ Toric lens takes precise astigmatism correction to the next level, with the enhanced image quality of an aspheric lens. We asked industry leaders about the potential impact of an aspheric toric lens, and how IOL innovation will shape the future of cataract surgery.

How do you think the addition of asphericity to the AcrySof^® Toric IOL will affect patient outcomes?

Robert Osher

Robert H. Osher, MD
Biography

Robert H. Osher, MD

Cincinnati Eye Institute
Cincinnati, Ohio

Robert H. Osher, MD served as Medical Director of Cincinnati Eye Institute for 20 years. He is a Professor of Ophthalmology at University of Cincinnati College of Medicine.

Dr. Osher has achieved worldwide recognition as a leader in cataract surgery. In addition to developing new techniques, he has designed many of the contemporary intraocular lenses and instruments used in cataract surgery. He has received the Lifetime Achievement Award from AAO and the Cornelius D. Binkhorst Medal of Honor from ASCRS. In April, he will receive The Charles D. Kelman Innovator’s Award in San Francisco.

Cincinnati Eye Institute

I am certain toric lenses will become the new standard. Every innovation is welcome as we move toward this inevitable and triumphant moment in cataract surgery.

TOPICS:

What role do you believe IOL innovation plays in advancing the field of cataract surgery? Where do you see IOL technology heading in the future?

What qualities are most important to you in a toric lens? How does asphericity fit into those needs?

How do you think the addition of asphericity to the AcrySof^® Toric IOL will affect patient outcomes?

What are the surgical benefits of an aspheric toric lens like AcrySof^® IQ Toric?

What effect do you think an aspheric toric lens like AcrySof^® IQ Toric will have on your practice?

New Technology Intraocular Lens (NTIOL) is a status given to lenses that provide patients with improved technology and new clinical benefits. As a member of the “Reduced Spherical Aberration” category established by CMS on February 27, 2006, Alcon’s AcrySof^® IQ Toric IOL recently received NTIOL status.

Ambulatory Surgery Centers are eligible to receive a payment adjustment of an additional $50 when AcrySof^® IQ Toric is used in cataract surgery on a Medicare beneficiary. This additional payment is effective through February 27, 2011.

Alcon is proud to develop the innovations that help shape the future of cataract surgery.

For more information, contact Alcon Reimbursement Services.

For more information on CMS and NTIOL, visit the CMS NTIOL Payment Page.

RESOURCES

	AcrySof^® IQ Toric Brochure Get the facts on AcrySof^® IQ Toric, including specs and studies.
	AcrySof^® IQ Toric Quick Guide Get up to speed on AcrySof^® IQ Toric with brief info, surgical considerations, and more.
	AcrySof^® IQ Toric Directions for Use Download the full technical specifications of the AcrySof^® IQ Toric IOL.
	AcrySof^® IQ Toric A-Constant FAQ Calculate a personalized A-Constant for AcrySof^® IQ Toric.
	AcrySof^® IQ Toric Patient Education Brochure Provide your patients with more information on cataract surgery and premium IOLs.
	AcrySof^® IQ Toric Calculator Makes precise surgical planning easy.

Where the Best Micro-Surgical Components Come Together as One

As part of the INTREPID^® Micro-Coaxial System, AcrySof^® IOLs offer advanced optics on a proven platform, to provide excellent ease of implantation and proven patient benefits.

Home About Conversation Invite a Colleague About Alcon Terms and Conditions Privacy Policy Other Alcon Products

Copyright © 2009 Alcon, Inc., a global company based in Hünenberg, Switzerland. Information contained here pertains to Alcon’s global operations and Alcon’s global product line. Not all products are approved in every market and approved labeling and instructions may vary by local country.

Currently AcrySof^® IQ Toric IOL is only available in the United States.

CAUTION: Federal law restricts this device to sale by or on the order of a physician. INDICATIONS: AcrySof^® IQ Toric IOL Models SN6AT3, SN6AT4, and SN6AT5 Posterior Chamber Intraocular lenses are intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and pre-existing corneal astigmatism secondary to the removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision. WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate. PRECAUTIONS: Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof^® Natural IOL and normal color vision. The effect on vision of the AcrySof^® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS^® or BSS PLUS^® Sterile Intraocular Irrigating Solutions. ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.